Gujarat Inject [GUJINJEC] vs Biocon [BIOCON] Detailed Stock Comparison

Gujarat Inject (Kerala) Ltd.

BSE
Loading...

Biocon Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gujarat Inject (Kerala) Ltd. wins in 4 metrics, Biocon Ltd. wins in 14 metrics, with 1 ties. Biocon Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gujarat Inject (Kerala) Ltd. Biocon Ltd. Better
P/E Ratio (TTM) 158.27 71.84 Biocon Ltd.
Price-to-Book Ratio 12.63 1.68 Biocon Ltd.
Debt-to-Equity Ratio 0.00 50.02 Tie
PEG Ratio -2.01 0.17 Biocon Ltd.
EV/EBITDA 93.74 19.22 Biocon Ltd.
Profit Margin (TTM) 2.51% 3.59% Biocon Ltd.
Operating Margin (TTM) 2.88% 7.63% Biocon Ltd.
EBITDA Margin (TTM) 2.88% 7.63% Biocon Ltd.
Return on Equity 10.16% 3.66% Gujarat Inject (Kerala) Ltd.
Return on Assets (TTM) 8.51% 1.72% Gujarat Inject (Kerala) Ltd.
Free Cash Flow (TTM) $-15.46M $17.18B Biocon Ltd.
Dividend Yield N/A 0.26% N/A
1-Year Return 425.15% 17.90% Gujarat Inject (Kerala) Ltd.
Price-to-Sales Ratio (TTM) 13.82 3.37 Biocon Ltd.
Enterprise Value $1.18B $643.51B Biocon Ltd.
EV/Revenue Ratio 11.69 3.82 Biocon Ltd.
Gross Profit Margin (TTM) 0.14% 67.91% Biocon Ltd.
Revenue per Share (TTM) $11 $133 Biocon Ltd.
Earnings per Share (Diluted) $0.60 $4.87 Biocon Ltd.
Beta (Stock Volatility) -0.90 0.25 Gujarat Inject (Kerala) Ltd.

Gujarat Inject (Kerala) Ltd. vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

GUJINJEC
BIOCON

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Gujarat Inject (Kerala) Ltd.-1.68%-2.42%13.59%63.41%279.75%225.27%
Biocon Ltd.-0.70%1.66%-3.27%10.34%6.50%7.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Gujarat Inject (Kerala) Ltd.425.15%1,090.00%3,947.62%3,947.62%3,947.62%3,947.62%
Biocon Ltd.17.90%71.09%5.03%250.57%603.49%1,357.39%

Performance & Financial Health Analysis: Gujarat Inject (Kerala) Ltd. vs Biocon Ltd.

MetricGUJINJECBIOCON
Market Information
Market Cap i₹1.38B₹566.52B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i22,2922,496,867
90 Day Avg. Volume i41,5073,790,310
Last Close₹117.00₹416.05
52 Week Range₹19.01 - ₹125.50₹331.00 - ₹440.40
% from 52W High-6.77%-5.53%
All-Time High₹125.50 (Jun 09, 2026)₹487.75 (Dec 21, 2020)
% from All-Time High-6.77%-14.70%
Growth Metrics
Quarterly Revenue Growth-0.44%0.09%
Quarterly Earnings Growth-0.82%4.73%
Financial Health
Profit Margin (TTM) i0.03%0.04%
Operating Margin (TTM) i0.03%0.08%
Return on Equity (TTM) i0.10%0.04%
Debt to Equity (MRQ) i0.0050.02
Cash & Liquidity
Book Value per Share (MRQ)₹7.52₹207.92
Cash per Share (MRQ)₹0.18₹45.84
Operating Cash Flow (TTM) i₹-31,076,498₹17.78B
Levered Free Cash Flow (TTM) i₹10.17M₹10.13B
Dividends
Last 12-Month Dividend Yield iN/A0.26%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Gujarat Inject (Kerala) Ltd. vs Biocon Ltd.

MetricGUJINJEC (Apr 24, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i158.2771.84
Forward P/E iN/A38.56
PEG Ratio i-2.010.17
Price to Sales (TTM) i13.823.37
Price to Book (MRQ) i12.631.68
Market Capitalization
Market Capitalization i₹1.38B₹566.52B
Enterprise Value i₹1.18B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i11.693.82
Enterprise to EBITDA i93.7419.22
Risk & Other Metrics
Beta i-0.900.25
Book Value per Share (MRQ) i₹7.52₹207.92

Financial Statements Comparison: Gujarat Inject (Kerala) Ltd. vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGUJINJEC (2025)BIOCON (2025)
Revenue/Sales i190.46M150.52B
Cost of Goods Sold i177.77M51.98B
COGS % of Revenue i93.3%34.5%
Gross Profit i12.68M98.54B
Gross Margin i6.7%65.5%
Research & Development iN/A6.34B
Operating Income (EBIT) i10.75M16.26B
Operating Margin i5.6%10.8%
EBITDA i12.56M33.60B
EBITDA Margin i6.6%22.3%
Pre-Tax Income i12.54M18.87B
Pre-Tax Income % of Revenue i6.6%12.5%
Income Tax i2.37M4.57B
Income Tax % of Revenue i1.2%3.0%
Net Income (Profit) i10.17M14.29B
Profit Margin i5.3%9.5%

Balance Sheet & Liquidity Metrics

MetricGUJINJEC (2025)BIOCON (2025)
Cash & Equivalents i262,78532.27B
Total Current Assets i99.75M162.86B
Total Current Assets % of Revenue i52.4%108.2%
Total Current Liabilities i19.38M143.34B
Total Current Liabilities % of Revenue i10.2%95.2%
Long-Term Debt i0129.45B
Long-Term Debt % of Revenue i0.0%86.0%
Total Shareholders Equity i100.12M277.13B
Retained Earnings iN/A189.59B
Retained Earnings % of Revenue i0.0%126.0%
Property, Plant & Equipment iN/A4.32B

Cash Flow Statement Comparison

MetricGUJINJEC (2025)BIOCON (2025)
Operating Cash Flow i-31.08M17.78B
Operating Cash Flow % of Revenue i-16.3%11.8%
Capital Expenditures i0-21.36B
Free Cash Flow i-15.46M17.18B
FCF Margin i-8.1%11.4%
Debt Repayment i-19.76M-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGUJINJECBIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.65M1.62B
Float Shares i1.00M583.07M
% Held by Insiders i63.90%54.07%
% Held by Institutions i0.00%24.88%
% Held by Public i36.10%21.05%

Dividend Analysis & Yield Comparison: Gujarat Inject (Kerala) Ltd. vs Biocon Ltd.

MetricGUJINJECBIOCON
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.26%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AJul 04, 2025